Prognostic value of cytokines (TNF-α, IL-10, Leptin) and C-reactive protein serum levels in adult patients with nosocomial sepsis

Öz

Anahtar Kelimeler

• -

Prognostic value of cytokines (TNF-α, IL-10, Leptin) and C-reactive protein serum levels in adult patients with nosocomial sepsis

Abstract

Objectives: The purpose of this trial was to investigate in patients with sepsis, the correlation between prognosis of disease and factors, which influence prognosis like gender, focus of infection, bacterial growth in blood culture, growing pathogens in addition to serum levels of cytokines (TNF-α, IL-10, leptin) and C-reactive protein. Material and methods: Forty-six adult patients with sepsis and 55 healthy adults as control group were enrolled in this study. Serum cytokine (TNF-α, IL-10 and leptin) levels were determined by ELISA method and C-reactive protein (CRP) levels were measured by nephelometric method. Serum cytokine and CRP levels on day 0 (initial), day 3 and day 5 were compared in surviving sepsis patients and patients who died because of sepsis. Results: Serum IL-10 level on day 0 (initial) of adult patients who died as a result of sepsis was found to be higher than surviving patients and the difference was statistically significant (p=0.025). On 3rd day of treatment, serum TNF-α and CRP levels of patients who dies because of sepsis were higher than values of surviving patients (for TNF-α p=0.033, for CRP p=0.026). In adult patient group with sepsis who died on the 5th day of treatment, serum TNF-α level was significantly higher than levels in surviving patients (p=0.030). Conclusion: It was determined that in patients who died due to sepsis, initial serum IL-10 level, TNF- α and CRP levels on 3rd day of treatment and finally on 5th day of treatment, only serum TNF- α level was higher than surviving patients. We believe that determining serum TNF-α and IL-10 levels in patients with sepsis before and during treatment will help clinicians to clarify prognosis and enable them to implement appropriate treatment modifications.

Keywords

• Sepsis
• cytokines
• CRP
• prognosis

Kaynakça

1. Opal SM. Severe sepsis and septic shock: defining the clinical problem Scand J Infect Dis 2003; 35 : 529-534.
2. de Pablo R, Monserrat J, Reyes E, Diaz-Martin D, Rodriguez Zapata M, Carballo F. Mortality in patients with septic shock correlates with anti-inflammatory but not proinflammatory immunomodulatory molecules. J Intensive Care Med 2011; 26 :125-132.
3. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997; 112 (6 Suppl): 321S-329S.
4. Özbalkan Z, Aslar AK, Yıldız Y, Aksaray S. Investigation of the course of proinflammatory and anti-inflammatory cytokines after burn sepsis. Int J Clin Pract 2004; 58: 125 – 129.
5. Jindal N, Hollenberg SM, Dellinger PR. Pharmacological issues in the management of septic shock. Critical Care Clinics North America 2000; 16: 233-250.
6. Martins GA, Carvalho MGC, Gattass CR. Sepsis: A follow-up of cytokine production in different phases of septic patients. Int J Molecular Med 2003; 11: 585 – 591.
7. Sesler CN, Perry JC, Varney KL. Management of severe sepsis and septic shock. Curr Opin Crit Care 2004; 10: 354-63.
8. Uzun Ö. [Pathogenesis of sepsis]. Edi: Uzun Ö. Sepsis and its sequelae. Hacettepe University Faculty of Medicine, Department of Infectious Diseases, 1996: 7-19. (Turkish)

9. Ünal N. [Diagnostic criteriaes of sepsis]. 1.Ankara University, Faculty of Medicine, Internal Diseases Days, Scientific Program and Abstract Book. Ankara, 2007: 162-163. (Turkish).
10. Balc RA. Severe sepsis and septic shock. Critical Care Clinic 2000; 16: 179-193.
11. Holmes CL, Russell JA, Walley Keith R. Genetic polymorphisms in sepsis and septic shock. Chest 2003; 124: 11031115.
12. Hempel L, Korholz D, Nussbaum P, Bönig H, Burdach S, Zintl F. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant 1997; 20: 365-368.
13. Faggioni R, Moser A, Feingold KR, Grunfeld C. Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Path 2000; 156: 1781-1787.
14. Balanco-Quiros A, Casado-Flores J, Arranz E, Garrote JA, Asensio J, Pérez A. Influence of leptin levels and body weight in survival of children with sepsis. Acta Paediatr 2002; 91: 626-631.
15. Bracho Riquelme RL, Reyes-Romero MA, Pescador N, Flores-Garcia AI. A leptin serum concentration less than 10ng/ml is a predictive marker of outcome in patients with moderate to severe secondary peritonitis. Eur Surg Res 2008; 41: 238-244.
16. Heper Y, Akalın H, Mıstık R, et al. Evaluation of serum Creaktive protein, procalsitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis. 2006; 25: 481-491.
17. Gogos CA, Drosou E, Bassaris HP, Shoutelis A. Pro-versus anti-inflammatoy cytokine profile in patiens with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000; 181: 176-180.
18. Şeki T, Taşova Y, Burgut R, Yaman A. [Diagnostic and prognostic importance of procalcitonin, CRP, IL-6, IL-8, and IL10]. Congress of Turkish Clinical Microbiology and Infectious Diseases. 2003. Abstract Book, s:316, Poster no: P10/02.
19. Csontos C, Foldi V, Palinkas L, et al. Time course of proand anti-inflammatory cytokine levels in patients with burnsPrognostic value of interleukin-10. Burns. 2009; 36: 483-494.
20. Lorente L, Martin MM, Labarta L, et al. Matrix metalloproteinase-9,-10, and tissue inhibitor matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care 2009; 13: R158.
21. Frink M, van Griensven M, Kobbe P, et al. Il-6 predicts organ dysfunction and mortality in patients with multiple injuries. Scand J Trauma Resusc Emerg Med 2009; 17:49-53.